PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $659,243 | -5.0% | 298,300 | +9.1% | 0.00% | 0.0% |
| Q1 2023 | $694,182 | +3.4% | 273,300 | -23.9% | 0.00% | 0.0% |
| Q4 2022 | $671,330 | -40.9% | 359,000 | -18.7% | 0.00% | -33.3% |
| Q3 2022 | $1,135,000 | +270.9% | 441,500 | +178.0% | 0.00% | +200.0% |
| Q2 2022 | $306,000 | -52.1% | 158,800 | -26.2% | 0.00% | -50.0% |
| Q1 2022 | $639,000 | -54.9% | 215,100 | -31.9% | 0.00% | -50.0% |
| Q4 2021 | $1,417,000 | -18.0% | 315,700 | -11.2% | 0.00% | 0.0% |
| Q3 2021 | $1,727,000 | -51.5% | 355,400 | -31.9% | 0.00% | -55.6% |
| Q2 2021 | $3,560,000 | -3.2% | 522,000 | +0.2% | 0.01% | -10.0% |
| Q1 2021 | $3,676,000 | +59.1% | 520,700 | +41.1% | 0.01% | +66.7% |
| Q4 2020 | $2,310,000 | +652.4% | 369,000 | +549.6% | 0.01% | +500.0% |
| Q3 2020 | $307,000 | +184.3% | 56,800 | +175.7% | 0.00% | – |
| Q2 2020 | $108,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |